Ajanta Pharma Q3 Results: Net profit up 11% at Rs 233 crore

7 hours ago 1

Ajanta Pharma connected Thursday said its consolidated nett aft taxation accrued by 11 per cent on-year to Rs 233 crore for the 3rd 4th ended December 31, 2024.

The cause steadfast had reported a nett aft taxation (PAT) of Rs 210 crore successful the October-December play of past fiscal.

Revenue from operations stood astatine Rs 1,146 crore successful the 3rd 4th compared to Rs 1,105 crore successful the year-ago period, Ajanta Pharma said successful a regulatory filing.

Shares of the institution settled 1.64 per cent higher astatine Rs 2,670.70 apiece connected the BSE.

*** Disclaimer: This Article is auto-aggregated by a Rss Api Program and has not been created or edited by Nandigram Times

(Note: This is an unedited and auto-generated story from Syndicated News Rss Api. News.nandigramtimes.com Staff may not have modified or edited the content body.

Please visit the Source Website that deserves the credit and responsibility for creating this content.)

Watch Live | Source Article